Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

envirochem international pty ltd (receivers & managers a - phosphoric acid | sulfamic acid | sulfuric acid | benzalkonium chloride - dairy cleanser - farm vat | milking equipment | milking machine - bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wertheim laboratories pty ltd - phosphoric acid | sulfamic acid | sulfuric acid | benzalkonium chloride - dairy cleanser - farm vat | milking equipment | milking machine - bacteria

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dasco proprietary limited - phosphoric acid | sulfamic acid | sulfuric acid | benzalkonium chloride - dairy cleanser - dairy or milking shed | farm vat | milking equipment | milking machine - milkstone removal | thermoduric bacteria | milk fat | milk protein | mineral deposits

United States - English - NLM (National Library of Medicine)

energetix corporation - milk thistle (unii: u946sh95ee) (milk thistle - unii:u946sh95ee), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), echinacea angustifolia (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), bos taurus pituitary gland (unii: 7jm57i419k) (bos taurus pituitary gland - unii:7jm57i419k), thyroid, bovine (unii: mn18otn73w) (thyroid, bovine - unii:mn18otn73w) - milk thistle 12 [hp_x] in 1 ml - ​uses ​ ​ temporary relief of exhaustion, cravings, restless sleep.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), nitric acid (unii: 411vrn1tv4) (nitric acid - unii:411vrn1tv4), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), bisphenol a (unii: mlt3645i99) (bisphen - chelidonium majus 3 [hp_x] in 1 ml - for temporary relief of symptoms related to aspartame toxicity including headache, dizziness, mood changes, vomiting and nausea, abdominal cramps and pain, fatigue and weakness.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to aspartame toxicity including headache, dizziness, mood changes, vomiting and nausea, abdominal cramps and pain, fatigue and weakness.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), nitric acid (unii: 411vrn1tv4) (nitric acid - unii:411vrn1tv4), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), bisphenol a (unii: mlt3645i99) (bisphen - chelidonium majus 3 [hp_x] in 1 ml - for temporary relief of symptoms related to aspartame toxicity including headache, dizziness, mood changes, vomiting and nausea, abdominal cramps and pain, vision change, fatigue and weakness and memory loss.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), nitric acid (unii: 411vrn1tv4) (nitric acid - unii:411vrn1tv4), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), bisphenol a (unii: mlt3645i99) (bisphen - for temporary relief of symptoms related to aspartame toxicity including headache, dizziness, mood changes, vomiting and nausea, abdominal cramps and pain, fatigue and weakness.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to aspartame toxicity including headache, dizziness, mood changes, vomiting and nausea, abdominal cramps and pain, fatigue and weakness.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), cupric acetate (unii: 39m11xph03) (cupric cation - unii:8cbv67279l), ginkgo (unii: 19fuj2c58t) (ginkgo - unii:19fuj2c58t), dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), phosphoric acid (unii: e4ga8884nn) (phosphoric acid - unii:e4ga8884nn), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), sus scrofa cerebrum (unii: 4gb5dqr532) (sus scrofa cerebrum - unii:4gb5dqr532), ambergris (unii: xtc0d02p6c) (ambergris - unii:xtc0d02p6c), picric acid (unii: a49os0f91s) (picric acid - unii:a49os0f91s), chaste tree fruit (unii: 433osf3u8a) (chaste tree - unii:433osf3u8a), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), semecarpus anacardium juice (unii: y0f0bu8rdu) (semecarpus anacardium juice - unii:y0f0bu8rdu), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), cicuta virosa root (unii: yea9p21s8n) (cicuta virosa root - unii:yea9p21s8n), conium maculatum flowering top (unii: q28r5gf371) (conium maculatum flowering top - unii:q28r5gf371), helleborus niger root (unii: 608dgj6815) (helleborus niger root - unii:608dgj6815), lead (unii: 2p299v784p) (lead - unii:2p299v784p), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - agnus castus - forgetfulness, alumina - confusion, ambra grisea – absent mindedness, anacardium orientale - dullness, argentum nitricum - forgetfulness, baryta carbonica - dullness, cerebrum suis - confusion, cicuta virosa - forgetfulness, conium maculatum – absent mindedness, cuprum aceticum - confusion, ginkgo biloba - forgetfulness, helleborus niger -confusion, kali phosphoricum – absent mindedness, lycopodium clavatum - dullness, phosphoricum acidum - forgetfulness, picricum acidum - confusion, plumbum metallicum – absent mindedness, selenium metallicum - dullness, thiaminum hydrochloricum - forgetfulness, zincum metallicum - confusion. • for the temporary relief of symptoms including: • forgetfulness  • confusion • absent-mindedness  • dullness these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

martin winstead - phosphoric acid(540g/l)+quaternary ammonium cpd.(25g/l) - liquid - dairy cleanser - milking equipment | milking machine - milkstone removal | residue, dirt in milking equipment | thermoduric bacteria | water scale | milk fat | milk protein | mineral deposits

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 2.5 mg - attention deficit disorders , narcolepsy attention deficit disorders (previously known as minimal brain dysfunction in children). other terms being used to describe the behavioral syndrome below include: hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction. methylphenidate hydrochloride chewable tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. specific etiology of this syndrome is unknown, and there is no single diagnostic test. adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. characteristics commonly reported include: chronic history of short attention span, distractibility, emotional lability, impulsivity, and moderate-to-severe hyperactivity; minor neurological signs and abnormal eeg. learning may or may not be impaired. the diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of one or more of these characteristics. drug treatment is not indicated for all children with this syndrome. stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is generally necessary. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms. methylphenidate hydrochloride chewable tablet is contraindicated in patients known to be hypersensitive to methylphenidate or other components of the drug. methylphenidate hydrochloride chewable tablets are contraindicated during treatment with monoamine oxidase inhibitors, and also within a minimum of 14 days following discontinuation of a monoamine oxidase inhibitor (hypertensive crises may result).